| A novel transgenic mouse model of CBS-deficient homocystinuria does not incur hepatic steatosis or fibrosis and exhibits a hypercoagulative phenotype that is ameliorated by betaine treatment. Maclean K.N., Sikora J., Kozich V., Jiang H., Greiner L.S., Kraus E., Krijt J., Overdier K.H., Collard R., Brodsky G.L. et al.
Mol. Genet. Metab. 101:153-162(2010) · Mapped (23) |
| Cystathionine gamma-lyase: Clinical, metabolic, genetic, and structural studies. Kraus J.P., Hasek J., Kozich V., Collard R., Venezia S., Janosikova B., Wang J., Stabler S.P., Allen R.H., Jakobs C. et al.
Mol. Genet. Metab. 97:250-259(2009) · Mapped (3) |
| New insights into intra- and intermolecular interactions of immunoglobulins: crystal structure of mouse IgG2b-Fc at 2.1-A resolution. Kolenko P., Dohnalek J., Duskova J., Skalova T., Collard R., Hasek J.
Immunology 126:378-385(2009) · Mapped (1) |
| Stabilization of antibody structure upon association to a human carbonic anhydrase IX epitope studied by X-ray crystallography, microcalorimetry, and molecular dynamics simulations. Kral V., Mader P., Collard R., Fabry M., Horejsi M., Rezacova P., Kozisek M., Zavada J., Sedlacek J., Rulisek L. et al.
Proteins 71:1275-1287(2008) · UniProtKB (1) · Mapped (1) |
| Kallikrein 4 is a potential mediator of cellular interactions between cancer cells and osteoblasts in metastatic prostate cancer. Gao J., Collard R.L., Bui L., Herington A.C., Nicol D.L., Clements J.A.
Prostate 67:348-360(2007) · Mapped (14) |
| Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells. Veveris-Lowe T.L., Lawrence M.G., Collard R.L., Bui L., Herington A.C., Nicol D.L., Clements J.A.
Endocr. Relat. Cancer 12:631-643(2005) · Mapped (20) |
| The collagenase gene family in humans consists of at least four members. Muller D., Quantin B., Gesnel M.-C., Millon-Collard R., Abecassis J., Breathnach R.
Biochem. J. 253:187-192(1988) · UniProtKB (2) |
